1. ScholarBank@NUS

VASUDEVAN SUBHASH

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
VASUDEVAN SUBHASH
Variants
Vasudevan, S.G.
Vasudevan, S.
 
Main Affiliation
 
Faculty
 
Email
gmsvsg@nus.edu.sg
 

Publications

Results 1-20 of 49 (Search time: 0.008 seconds).

Issue DateTitleAuthor(s)
12015A Crystal Structure of the Dengue Virus NS5 Protein Reveals a Novel Inter-domain Interface Essential for Protein Flexibility and Virus ReplicationZhao Y.; Soh T.S.; Zheng J.; Chan K.W.K.; Phoo W.W.; Lee C.C.; Tay M.Y.F.; Swaminathan K. ; Cornvik T.C.; Lim S.P.; Shi P.-Y.; Lescar J.; Vasudevan S.G. ; Luo D.
23-Apr-2012A human PrM antibody that recognizes a novel cryptic epitope on dengue E glycoproteinChan, A.H.Y.; Tan, H.C.; Chow, A.Y.; Lim, A.P.C.; Lok, S.M.; Moreland, N.J.; Vasudevan, S.G. ; MacAry, P.A.; Ooi, E.E.; Hanson, B.J.
3Oct-2010A method for full genome sequencing of all four serotypes of the dengue virusChristenbury, J.G.; Aw, P.P.K.; Ong, S.H.; Schreiber, M.J.; Chow, A.; Gubler, D.J. ; Vasudevan, S.G. ; Ooi, E.E.; Hibberd, M.L.
4May-2009A small-molecule dengue virus entry inhibitorWang, Q.-Y.; Patel, S.J.; Vangrevelinghe, E.; Hao, Y.X.; Rao, R.; Jaber, D.; Schul, W.; Gu, F.; Heudi, O.; Ngai, L.M.; Mee, K.P.; Wai, Y.P.; Keller, T.H.; Jacoby, E.; Vasudevan, S.G. 
5Dec-2011Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse modelRathore, A.P.S. ; Paradkar, P.N.; Watanabe, S.; Tan, K.H.; Sung, C.; Connolly, J.E.; Low, J.; Ooi, E.E.; Vasudevan, S.G. 
62016Characterization of RyDEN (C19orf66) as an Interferon-Stimulated Cellular Inhibitor against Dengue Virus ReplicationSuzuki Y.; Chin W.-X.; Han Q.; Ichiyama K.; Lee C.H.; Eyo Z.W.; Ebina H.; Takahashi H.; Takahashi C.; Tan B.H.; Hishiki T.; Ohba K.; Matsuyama T.; Koyanagi Y.; Tan Y.-J. ; Sawasaki T.; Chu J.J.H. ; Vasudevan S.G. ; Sano K.; Yamamoto N.
7Mar-2014Chikungunya virus nsP3 & nsP4 interacts with HSP-90 to promote virus replication: HSP-90 inhibitors reduce CHIKV infection and inflammation in vivoRathore, A.P.S. ; Haystead, T.; Das, P.K.; Merits, A.; Ng, M.-L.; Vasudevan, S.G. 
82015Comparison of incidence of ptosis after combined phacotrabeculectomy with mitomycin C and phacoemulsificationKoh V. ; Tatsios J. ; Chew P.T.K. ; Amrith S.
92008Decision tree algorithms predict the diagnosis and outcome of dengue fever in the early phase of illnessTanner L.; Schreiber M.; Low J.G.H.; Ong A.; Tolfvenstam T.; Lai Y.L.; Ng L.C.; Leo Y.S.; Puong L.T.; Vasudevan S.G. ; Simmons C.P.; Hibberd M.L.; Ooi E.E. 
10Oct-2011Dengue protease activity: The structural integrity and interaction of NS2B with NS3 protease and its potential as a drug targetPhong, W.Y.; Moreland, N.J.; Lim, S.P.; Wen, D.; Paradkar, P.N.; Vasudevan, S.G. 
112007Dengue virus serotype infection specifies the activation of the unfolded protein responseUmareddy I.; Pluquet O.; Wang Q.Y.; Vasudevan S.G. ; Chevet E.; Gu F.
12Oct-2009Depletion of macrophages in mice results in higher dengue virus titers and highlights the role of macrophages for virus controlFink, K.; Ng, C.; Nkenfou, C.; Vasudevan, S.G. ; Van Rooijen, N.; Schul, W.
132013Differential unfolded protein response during Chikungunya and Sindbis virus infection: CHIKV nsP4 suppresses eIF2α phosphorylationRathore, A.P.S. ; Ng, M.-L.; Vasudevan, S.G. 
14Oct-2012Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trialWatanabe, S.; Rathore, A.P.S. ; Sung, C.; Lu, F.; Khoo, Y.M.; Connolly, J.; Low, J.; Ooi, E.E.; Lee, H.S.; Vasudevan, S.G. 
15Dec-2012Establishment of a robust dengue virus NS3-NS5 binding assay for identification of protein-protein interaction inhibitorsTakahashi, H.; Takahashi, C.; Moreland, N.J.; Chang, Y.-T. ; Sawasaki, T.; Ryo, A.; Vasudevan, S.G. ; Suzuki, Y.; Yamamoto, N.
16Feb-2013Exploring the binding of peptidic West Nile virus NS2B-NS3 protease inhibitors by NMRKang, C.; Gayen, S.; Wang, W.; Severin, R.; Chen, A.S.; Lim, H.A.; Chia, C.S.B.; Schüller, A. ; Doan, D.N.P.; Poulsen, A.; Hill, J.; Vasudevan, S.G. ; Keller, T.H.
17Mar-2012Expression and immunoaffinity purification of recombinant dengue virus 2 NS1 protein as a cleavable SUMOstar fusionRozen-Gagnon, K.; Moreland, N.J.; Ruedl, C.; Vasudevan, S.G. 
182016Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever PatientsSung C.; Wei Y.; Watanabe S.; Lee H.S.; Khoo Y.M.; Fan L.; Rathore A.P.S.; Chan K.W.-K.; Choy M.M.; Kamaraj U.S.; Sessions O.M.; Aw P.; de Sessions P.F.; Lee B.; Connolly J.E.; Hibberd M.L.; Vijaykrishna D.; Wijaya L.; Ooi E.E. ; Low J.G.-H.; Vasudevan S.G. 
19Nov-2010Fine-tuning DNA/albumin polyelectrolyte interactions to produce the efficient transfection agent cBSA-147Eisele, K.; Gropeanu, R.A.; Zehendner, C.M.; Rouhanipour, A.; Ramanathan, A.; Mihov, G.; Koynov, K.; Kuhlmann, C.R.W.; Vasudevan, S.G. ; Luhmann, H.J.; Weil, T. 
2011-Jun-2010Flexibility between the protease and helicase domains of the dengue virus NS3 protein conferred by the linker region and its functional implicationsLuo, D.; Wei, N.; Doan, D.N.; Paradkar, P.N.; Chong, Y.; Davidson, A.D.; Kotaka, M.; Lescar, J.; Vasudevan, S.G.